Dr. Paul D. Woolf, an “expert witness” at a pre-trial hearing said there is no significant link between AstraZeneca’s antipsychotic drug Seroquel and diabetes, according to a recent article from Bloomberg. AstraZeneca, which faces more than 14,000 lawsuits in the U.S. claiming it hid the drug’s diabetes risk, wants to call Woolf to testify in the upcoming trials.
(See AstraZeneca’s Antipsychotic Drug May Cause Diabetes, Sept. 23, 2009)
The drug saw sales of $4.45 billion in 2008. AstraZeneca says it has spent $623 million so far in legal costs related to the defense of Seroquel. Company officials say the first trials could take place in January in state court in Delaware and New Jersey.
To receive free news updates from Diabetes News Hound delivered straight to your Inbox, sign up here.
If you already receive the free Alerts, spread the word by telling a friend to sign up here.
